SK Bioscience Launches RSV Prevention Campaign at Baby Fair

Promotional Booth at COEX
Raising Awareness of RSV Disease

SK Bioscience is taking proactive measures to prevent RSV (respiratory syncytial virus) infections, which are known to spread widely during the fall and winter seasons.

RSV Prevention Campaign Booth at the 48th COEX Baby Fair Operated by SK Bioscience. SK Bioscience

SK Bioscience announced that it will participate in the 48th Baby Fair, held at COEX in Gangnam-gu, Seoul from August 14 to 17, and operate a promotional booth to raise awareness about the importance of RSV disease prevention. The booth is designed to provide information about RSV to parents of infants and young children, as well as pregnant women, and to educate them on proper preventive measures ahead of the fall season, when RSV cases typically begin to rise.

During the event, SK Bioscience will screen informational videos introducing RSV and outlining prevention guidelines, offer one-on-one on-site consultations with professional nurses, and conduct an RSV awareness survey targeting pregnant women and other visitors. As the Baby Fair is the largest exhibition in Korea focused on pregnancy, childbirth, and parenting, SK Bioscience plans to actively promote the campaign to enhance public awareness of RSV and foster a culture of prevention.

RSV generally causes symptoms similar to the common cold, such as coughing, runny nose, and fever. However, it can progress to severe illness and is the most common cause of bronchiolitis and pneumonia in infants under one year of age. It is known that 90% of infants and young children worldwide contract RSV before the age of two. The earlier the infection occurs, the longer the recovery time and the higher the risk of developing asthma, underscoring the importance of prevention and early treatment.

In particular, high-risk groups-including premature infants, individuals with heart or lung disease, immunocompromised patients, and the elderly-may experience severe respiratory distress that requires hospitalization, and in rare cases, the infection can be fatal. Because RSV can be transmitted not only through droplets from coughing or sneezing but also via hands or contaminated surfaces, adherence to preventive measures such as handwashing and hygiene management is strongly emphasized.

Major global health organizations, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), recommend long-acting RSV preventive antibody injections for infants and high-risk children entering their first RSV season. A single injection at the beginning of the RSV season provides protection for about five months, helping to prevent lower respiratory tract diseases caused by RSV.

Yoo Soo-an, Head of Domestic Marketing at SK Bioscience, stated, "RSV spreads rapidly, and for infants and young children whose bronchi and lungs are still developing, the disease can worsen into bronchiolitis or pneumonia, potentially leading to hospitalization. Through this campaign, we aim to encourage more parents to be vigilant about RSV and to actively participate in preventive activities."

This content was produced with the assistance of AI translation services.